Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
660-01-013 MRI in Clinical Practice Abstract

MRI in Clinical Practice: Diagnosis of Renal Inflammatory Myofibroblastic Tumor

Primary: Body - Kidney
Secondary: Analysis Methods - Classification and Prediction
660-01-013 · A Tour of Body Oncology · Thursday, 14 May, 8:30 AM–9:25 AM · Digital Posters Row A
Keywords: Magnetic resonance imaging Differential Diagnosis Renal tumor Inflammatory myofibroblastic tumor
Accepted
Hongyang Du 1, Jingyun Wu1, He Wang1, Naishan Qin1
1Radiology Department, Peking University First Hospital, Beijing, China
Presenting Author: Hongyang Du

Synopsis

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Brunn H (1939) TWO INTERESTING BENIGN LUNG TUMORS OF CONTRADICTORY HISTOPATHOLOGY: Remarks on the Necessity for Maintaining the Chest Tumor Registry. Journal of Thoracic Surgery 9:119–131. https://doi.org/10.1016/S0096-5588(20)32030-4 [doi]
2. Pothadiyil AJ, Bhat S, Paul F, et al (2016) Inflammatory Myofibroblastic Tumor of the Kidney: A Rare Renal Tumor. J Clin Diagn Res 10:ED17–ED18. https://doi.org/10.7860/JCDR/2016/22465.8856 [doi]
3. Fletcher CDM, Unni KK, Mertens F (2002) World Health Organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone. IARC Press, Lyon
4. Choi JH (2025) Inflammatory Myofibroblastic Tumor: An Updated Review. Cancers 17:1327. https://doi.org/10.3390/cancers17081327 [doi]
5. Cui M, Wei C, Sun W, Wang J (2024) Renal inflammatory myofibroblastic tumor. Asian Journal of Surgery 47:760–761. https://doi.org/10.1016/j.asjsur.2023.10.024 [doi]
6. Han Y, Yang G, Du J, et al (2023) The MRI features of renal inflammatory pseudotumor: A case report and literature review. Medicine (Baltimore) 102:e33287. https://doi.org/10.1097/MD.0000000000033287 [doi]
7. Chmiel P, SłOWIKOWSKA A, Banaszek Ł, et al (2024) Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment. Oncol Res 32:1141–1162. https://doi.org/10.32604/or.2024.050350 [doi]
8. Pedrosa I, Cadeddu JA (2022) How We Do It: Managing the Indeterminate Renal Mass with the MRI Clear Cell Likelihood Score. Radiology 302:256–269. https://doi.org/10.1148/radiol.210034 [doi]
9. Shetty AS, Fraum TJ, Ballard DH, et al (2023) Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User’s Guide. Radiographics 43:e220209. https://doi.org/10.1148/rg.220209 [doi]
10. Fisch AE, Brodey PA (1976) Plasma cell granuloma of kidney. Urology 8:89–91. https://doi.org/10.1016/0090-4295(76)90066-2 [doi]
11. Lawrence B, Perez-Atayde A, Hibbard MK, et al (2000) TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 157:377–384. https://doi.org/10.1016/S0002-9440(10)64550-6 [doi]
12. Mahajan P, Casanova M, Ferrari A, et al (2021) Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges. Curr Probl Cancer 45:100768. https://doi.org/10.1016/j.currproblcancer.2021.100768 [doi]
13. Liang W, Zhou X, Xu S, Lin S (2016) CT Manifestations of Inflammatory Myofibroblastic Tumors (Inflammatory Pseudotumors) of the Urinary System. AJR Am J Roentgenol 206:1149–1155. https://doi.org/10.2214/AJR.15.14494 [doi]
14. Larbcharoensub N, Chobpradit N, Kijvikai K, Chalermsanyakorn P (2006) Primary renal inflammatory myofibroblastic tumor. Urol Int 76:94–96. https://doi.org/10.1159/000089745 [doi]
15. Moring N, Swerdloff D, Htoo A, et al (2024) Inflammatory myofibroblastic tumor of the genitourinary tract: a narrative review. Transl Androl Urol 13:308–319. https://doi.org/10.21037/tau-23-471 [doi]
16. Chen B, Li S, Fang X, et al (2020) Inflammatory Myofibroblastic Tumor of the Urinary System on Computed Tomography at a High-Volume Institution in China. Urol Int 104:960–967. https://doi.org/10.1159/000506779 [doi]
17. Hori J-I, Komiyama M (2009) A case of inflammatory myofibroblastic tumor of the kidney with cystic change. Jpn J Clin Oncol 39:410. https://doi.org/10.1093/jjco/hyp055 [doi]
18. Guo T, Zhang X, Chen S, et al (2024) Targeting lipid biosynthesis on the basis of conventional treatments for clear cell renal cell carcinoma: A promising therapeutic approach. Life Sci 336:122329. https://doi.org/10.1016/j.lfs.2023.122329 [doi]
19. Kapusta LR, Weiss MA, Ramsay J, et al (2003) Inflammatory myofibroblastic tumors of the kidney: a clinicopathologic and immunohistochemical study of 12 cases. Am J Surg Pathol 27:658–666. https://doi.org/10.1097/00000478-200305000-00009 [doi]
20. Abduljawad H, Aslan A, Aldoseri K, et al (2020) Rare presentation of inflammatory myofibroblastic tumor in the kidney. Radiol Case Rep 15:1266–1270. https://doi.org/10.1016/j.radcr.2020.05.043 [doi]
21. Wu W, Liang T, Zhang H (2025) Case Report: A case report of the diagnosis of renal inflammatory myofibroblastic tumor. Front Oncol 15:1543858. https://doi.org/10.3389/fonc.2025.1543858 [doi]
22. Raman SP, Johnson PT, Allaf ME, et al (2013) Chromophobe Renal Cell Carcinoma: Multiphase MDCT Enhancement Patterns and Morphologic Features. American Journal of Roentgenology 201:1268–1276. https://doi.org/10.2214/AJR.13.10813 [doi]
23. Marko J, Craig R, Nguyen A, et al (2021) Chromophobe Renal Cell Carcinoma with Radiologic-Pathologic Correlation. RadioGraphics 41:1408–1419. https://doi.org/10.1148/rg.2021200206 [doi]
24. Schieda N, Davenport MS, Silverman SG, et al (2022) Multicenter Evaluation of Multiparametric MRI Clear Cell Likelihood Scores in Solid Indeterminate Small Renal Masses. Radiology 303:590–599. https://doi.org/10.1148/radiol.211680 [doi]
25. Cui MQ, He B, Xu W, et al (2022) Value of clear cell likelihood score in differentiation between renal oncocytoma and clear cell renal cell carcinoma. Zhonghua Yi Xue Za Zhi 102:3779–3785. https://doi.org/10.3760/cma.j.cn112137-20221020-02193 [doi]
26. Hao Y-W, Zhang Y, Guo H-P, et al (2023) Differentiation between renal epithelioid angiomyolipoma and clear cell renal cell carcinoma using clear cell likelihood score. Abdom Radiol (NY) 48:3714–3727. https://doi.org/10.1007/s00261-023-04034-5 [doi]
27. Sun MRM, Ngo L, Genega EM, et al (2009) Renal Cell Carcinoma: Dynamic Contrast-enhanced MR Imaging for Differentiation of Tumor Subtypes—Correlation with Pathologic Findings. Radiology 250:793–802. https://doi.org/10.1148/radiol.2503080995 [doi]
28. Marko J, Craig R, Nguyen A, et al (2021) Chromophobe Renal Cell Carcinoma with Radiologic-Pathologic Correlation. RadioGraphics 41:1408–1419. https://doi.org/10.1148/rg.2021200206 [doi]
29. Calaway AC, Gondim D, Idrees M, Boris RS (2014) Spontaneous resolution of inflammatory myofibroblastic tumor of the kidney. Can J Urol 21:7582–7585
30. Li JY, Yong TY, Coleman M, et al (2010) Bilateral renal inflammatory pseudotumour effectively treated with corticosteroid. Clin Exp Nephrol 14:190–198. https://doi.org/10.1007/s10157-009-0242-y [doi]
31. Zhang G-H, Guo X-Y, Liang G-Z, Wang Q (2019) Kidney inflammatory myofibroblastic tumor masquerading as metastatic malignancy: A case report and literature review. WJCC 7:4366–4376. https://doi.org/10.12998/wjcc.v7.i24.4366 [doi]
32. Xie Y, Chen L, Ma X, et al (2017) Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis. Sci Rep 7:44281. https://doi.org/10.1038/srep44281 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/660-01-013